SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Elite football players 'more likely to develop dementia'
Fri March 17th - Elite male footballers are more likely to develop dementia than the general population, according to a Swedish study published today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Nervous system findings could revolutionise pain research

Friday July 29th, 2016

Decades of clinical trials of pain relief targeting a key chemical in the nervous system may have been based on misunderstandings of its role, British researchers have revealed.

Substance P is known to activate pain in the body and researchers had thought that neutralising it could create effective painkillers.

But clinical trials have been a failure - and now Leeds University researchers say they have an explanation.

This is that Substance P only activates pain in the central nervous system. In the peripheral nervous system, it reduces sensations of pain, making neurons less responsive and excitable, they report.

Researcher Professor Nikita Gamper said he was "really surprised" by the findings, discovered in conjunction with Hebei Medical University, China.

The findings come from work on cells in the laboratory and from animal studies and have been reported in the journal Antioxidants and Redox Signaling.

They suggest that Substance P could open the way to develop new pain relief for the peripheral nervous system.

Professor Gamper said: "We’ve discovered a paradox – that in the peripheral nervous system it acts as one of the body’s natural painkillers and actually suppresses pain.

“This means that when drugs were used in trials to suppress Substance P’s action in the central nervous system, they may have also prevented it from acting as a painkiller in the peripheral system. So, although the drugs looked like they worked in the lab, when they moved to clinical trials, they failed.”

He said: “If we could develop a drug to mimic the mechanism that Substance P uses, and ensured it couldn’t pass the blood brain barrier into the central nervous system, so was only active within the peripheral nervous system, it’s likely it could suppress pain with limited side effects.”

Redox-dependent modulation of T-type CA2+ channels in sensory neurons contributes to acute anti-nociceptive effect of Substance P Antioxidants and Redox Signaling 29 July 2016 [abstract]

Tags: Pain Relief | UK News

Printer friendly page Printer friendly page

CATEGORIES